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Abstract
Overview: The purpose of this study was to evaluate the role of Tumor Necrosis Factor-α (TNF-α) in insulin resistance (IR) during 
normal pregnancy.
Approach: This cross sectional study was carried out on 86 healthy pregnant women including 26, 23 and 37 individuals in the 1st, 2nd 
and 3rd trimesters, respectively, and in 21 healthy non pregnant women. Serum TNF-α concentration was measured by Enzyme Linked 
Immunosorbent Assay (ELISA) method.
Results: There were significant differences between serum TNF-α and IL-6 levels in pregnant women as compared with maternal 
healthy controls. There was significant correlation between gestational age and Body Mass Index (BMI) (r = 0.28, P = 0.01). There was 
no significant correlation between gestational age and insulin resistance (IR). We also did not find correlations between IR and TNF-α 
and IR and IL-6 in pregnant women.
Conclusion: In conclusion, our findings suggest that TNF-α and IL-6 are not greatly contributed to pregnancy induced insulin   resistance 
in normal pregnancy.
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Introduction
Pregnancy is related to glucose metabolism   disorders 
and insulin resistance.1–3 Insulin resistance may facil-
itate supply of appropriate nutrients particularly of 
glucose to the fetus for growth and metabolism. The 
mechanism responsible for insulin resistance has not 
been clearly established. Recent research shows that 
adipokinins  including  leptin4  resistin5  interleukin-6 
(IL-6)6  and  TNF-α7–10  play  an  important  role  in 
insulin resistance. TNF-α is one of the most widely 
studied cytokinins produced by adipose tissue. This 
  cytokinin is also secreted by placenta.11,12 TNF-α has 
an   important role in obesity-induced insulin   resistance 
and diabetes.7,10,13,14 A few studies suggest that TNF-α 
may play a role in insulin resistance in normal and 
diabetogenic  pregnant  women8,13,15    Interleukine-6 
is another cytokinine produced by immune and non 
immune cells.16–18
There are reports regarding its role in the patho-
genesis of insulin resistance.7,19–21 Insulin sensitivity 
changes from an enhanced state during early preg-
nancy to an insulin resistant state in late pregnancy.3,8,22 
Therefore, it is suspected, subsequent to increase in 
IR during pregnancy, its related   factors change too. 
However, at the time of our study we did not find any 
research had been done about changes in serum IL-6 
and TNF-α levels during different trimesters of nor-
mal pregnancy and their relationships to insulin resis-
tance. Therefore, the aim of this study is to determine 
the association of insulin resistance with serum inter-
leukin-6 and TNF-α levels during normal pregnancy.
Methods
This  study  was  conducted  at  the  Department  of 
Obstetrics and Gynecology of Honary Clinic, Jahrom, 
Iran.  Subjects  were  86  pregnant  women  with 
different gestational ages (first trimester: 26, second 
trimester: 23, third trimester: 37, and 21 non pregnant 
women similar in age and body mass index (BMI)). All 
subjects met the following criteria: no history of pre- 
gestational diabetes; no history of liver, respiratory, 
thyroid or other illness or any current infectious con-
dition. They were not on any drug therapy.
Body mass index (BMI, Kg/m2) was calculated 
according  to  the  maternal  height  and  prepreg-
nacy  weight.  Serum  samples  were  analyzed  for 
concentrations of IL-6, TNF-α, insulin and glucose. 
Blood  sugar  was  measured  by  glucose  oxidase/ 
peroxidase (GOD-POD) method. Serum insulin was 
determined by ELISA (Diaplus; based on the direct 
sandwich technique in which two monoclonal anti-
bodies are directed against separate antigenic deter-
minants on the insulin molecule. During incubation 
insulin  in  the  sample  reacts  with  enzyme  (HRP) 
conjugated anti-insulin antibody and anti-insulin anti-
body bound to micro-titration well. A sample washing 
step  removed  unbound  enzyme  labeled  antibody. 
In  the  insulin  ELISA,  the  bound  HRP  complex  is 
detected by reaction with TMB substrate. The reaction 
is stopped by adding acid to give a colorimetric end-
point that is read using ELISA reader). Serum TNF-α 
was assayed by ELISA (Bendermed, Austria Ref NO: 
BMF 223; It is based on the direct sandwich tech-
nique with biotin-Streptavidin, in which two mono-
clonal antibodies are directed against human TNF-α. 
Human TNF- present in the sample or standard binds 
to antibodies adsorbed to the microwells. A biotin-
conjugated anti-human TNF- antibody is added and 
binds to human TNF- captured by the first antibody. 
Following  incubation  unbound  biotin-conjugated 
anti-human  TNF-  antibody  is  removed  during  a 
wash step. Streptavidin-HRP is added and binds to 
the    biotin-conjugated  anti-human  TNF-  antibody. 
  Following incubation unbound Streptavidin-HRP is 
removed during a wash step, and substrate solution 
reactive with HRP is added to the wells. A coloured 
product is formed in proportion to the amount of human 
TNF- present in the sample or standard. The reaction 
is terminated by addition of acid and absorbance is 
measured at 450 nm. A standard curve is prepared 
from 7 human TNF- standard dilutions and human 
TNF- sample concentration determined). Serum IL-6 
was measured by ELISA (Bendermed, Austria Ref 
NO:  BMS213HS;).  Insulin  resistance  value  were 
calculated using the homeostasis model assessment, 
HOMA- IR,as (fasting insulin IU/L) × (fasting glucose 
mmol/L)/22.5 as previously reported by Matthows.23
The study was approved by the ethical commit-
tee of Jahrom University of Medical Sciences. All 
participants in the study filled and signed informed 
consent letter.
All results are displayed as mean ± SD (standard 
devation  of  mean).  Insulin  resistance  (IR),  BMI 
and body weight data were analyzed with One Way 
analysis of Variance (ANOVA). Serum IL-6, TNF-α 
and insulin concentration data were analyzed with Association of insulin resistance with IL-6 and TNF-α
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Table 1. clinical and laboratory characteristic of subjects.
non pregnant 
women
pregnant 
women
number of case 21 86
Age (year) 27.2 ± 5.6 26.4 ± 4.1
gestational age (week) 23.9 ± 9.8
hT (m) 1.58 ± 0.07 1.6 ± 0.06
WT (Kg) 58.6 ± 6.4 64.99 ± 11.5**
BMI (Kg/m2) 23.4 ± 3 25.4 ± 3.7*
SBP (mmhg) 110.7 ± 5.9 117 ± 7.8**
DBP (mmhg) 70.9 ± 11.4 72.8 ± 6.9
BgL (mg/100) 80.2 ± 8.7 81.5 ± 8.7
Insulin (μLU/mL) 8.7 ± 1.9 10.9 ± 6
IL-6 (pg/mL) 0.3 ± 0.35 2.6 ± 2.1***
TnF (pg/mL) 0.8 ± 0.7 2.8 ± 1.9***
Ir 1.7 ± 0.4 2.1 ± 0.7*
notes: *P , 0.05 (control); **P , 0.01 (control); ***P , 0.0001 (control).
Abbreviations: BMI, body max index; hT, height of women; WT, weight 
of body; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
BgL, blood glucose level; Ir, insulin resistance.
non-parametric kruskal-wallis test followed by Mann 
Whitney U-test. Correlations were calculated using 
liner  correlation  (Pearson).  Statistical  analysis  was 
performed using SPSS 11 for Windows. P , 0.05 was 
considered statistically significant for all analysis.
Results
A  total  of  86  pregnant  women  and  21  non  preg-
nant subjects participated in the study. Clinical and 
laboratory  characteristics  of  subjects  are  summa-
rized in Table 1. Body mass index was significantly 
  different in the third trimester as compared with non 
  pregnant and women with first trimester of pregnancy 
(Fig. 1A, Table 2). In terms of systolic pressure, sub-
jects in the second and third trimester of pregnancy 
were significantly different compared to non pregnant 
women (Fig. 1B). There was statistical difference in 
serum IL-6 concentration between the non pregnant 
women and subjects in first, second and third trimes-
ter of pregnancy (Table 2, Fig. 1C). TNF-α level was 
also significantly higher in patients in all gestational 
age as compared to non pregnant women (Fig. 1D). 
  However, during pregnancy TNF-α level decreased 
by increasing in the gestational age (Table 2). Preg-
nant  women  exhibited  higher  score  of  HOMA  IR 
compared to non pregnant subjects group, however, 
there was no difference in this score between pregnant 
subjects in different gestational age (Tables 1 and 2). 
There was significant correlation between gestational 
age and BMI (r = 0.28, P = 0.01), diastolic pressure 
(r = 0.28, P = 0.01) IL-6 (r = −0.52, P = 0.000) and 
TNF-α level (r = −0.44, P , 0.0001). There was no 
significant correlation between   gestational age and 
IR. IL-6 level in pregnancy and no correlation with 
IR,  fasting  insulin,  BMI  and  body  weight. TNF-α 
level also did not show correlation with IR, fasting 
insulin, BMI and body weight.
Discussion
Glucose metabolism disorder is a common compli-
cation during pregnancy and its pathology is associ-
ated with IR and deficiency of insulin secretion.2 This 
study showed that insulin resistance was significantly 
different in pregnant group in general compared to 
non pregnant subjects. In spite of a previous report 
we did not found correlation between gestational age 
and insulin resistance. Our finding was in contrast 
to the results of Kirwan et al,8 Melczer et al9 and 
Consultant et al3 in which they showed insulin resis-
tance was significantly increased in the late pregnancy 
compared with either non pregnant or early   pregnancy. 
This difference may be due to   differences in dietary 
composition, life style between western and eastern 
societies,24 variability between insulin assays in differ-
ent experimental researches,25 differences in the pop-
ulation study and sampling time during pregnancy.
A  number  of  studies  have  reported  concentra-
tions of IL-6 in pregnant subjects.21,26–28 Our data are 
inconsistent  with  several  pervious  observations  that 
found an increase in IL-6 level in pregnant compared 
to non-pregnant subjects.26 IL-6 is a pro inflammatory 
cytokine that has important role in on-time parturition 
and success of pregnancy.27,29 There are limited and 
partially contradictory reports concerning the   pattern 
of IL-6 secretion during normal pregnancy.26–28 In the 
present study, maternal serum IL-6 has decreased with 
further increasing in pregnancy period. In this regard, 
our results were in contrast with Doria et al and Curry 
et al.29,30 We speculate, that this discrepancy was prob-
ably caused by different biochemical assays for deter-
mination of serum IL-6,28 and differences in survey 
population.30 In addition, several other variables may 
influence cytokine levels during pregnancy including 
maternal age, prepregnancy body mass index and prior 
preterm delivary status.31 In the present study, we did 
not find any correlation between maternal IL-6 and 
insulin resistance.Jahromi et al
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Table 2. clinical and laboratory characteristics of pregnant women with different gestational age.
3rd trimester 
mean ± sD
2nd trimester 
mean ± sD
1st trimester 
mean ± sD
number of cases 37 23 26
Age (year) 27.6 ± 4.7 24.9 ± 2.3 25.5 ± 4.1
gA (week) 32.9 ± 4.3 22.2 ± 2.7 11.2 ± 1.6
WT (Kg) 68.2 ± 10.6** 65.7 ± 12.6 59.2 ± 10.2
hT (m) 1.6 ± 0.07 1.58 ± 0.06 1.58 ± 0.06
SBP (mmhg) 118.3 ± 7* 117.5 ± 7.7 114.2 ± 8.7
DBP (mmhg) 74.7 ± 6.5 71.7 ± 7.1 70.5 ± 6.6
BMI (Kg/m2) 26.2 ± 3.6** 25.7 ± 3.7 23.6 ± 3.6
BgL (mg/100) 84.1 ± 21.2 79.4 ± 6.7 78.6 ± 6.7
Insulin (μL/mL) 10.05 ± 3.9 10.6 ± 3.8 10.5 ± 3.4
IL-6 (pg/mL) 1.6 ± 0.8** 2.6 ± 1.4 4 ± 2.9
TnF (pg/mL) 1.9 ± 1.1*** 2.88 ± 1.6* 3.93 ± 2.2
Ir 2.1 ± 0.8 2.1 ± 0.6 2 ± 0.6
notes: *P , 0.05; **P , 0.01; ***P , 0.001 (significantly different from pregnant women in 1st trimester).
Abbreviations: BMI, body mass index; gA, gestational age; WT, wight of body; hT, height; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
BgL, blood glucose level; Ir, insulin resistance.
Figure 1 A) BMI in patients in different trimesters of pregnancy and non pregnant subjects. BMI were significantly higher in 3rd trimesters   compared with 
the control (**P , 0.01). B) Systolic blood pressure in different trimesters of pregnancy and non pregnant subjects. B) Systolic blood pressure was signifi-
cantly higher in the 2nd and 3rd trimesters as compared with non pregnant subjects (*P , 0.05; **P , 0.01). c) Serum IL-6 level in different trimesters of 
pregnancy and non pregnant subjects. Serum IL-6 level was significantly higher in the 1st, 2nd and 3rd trimester as compared with non pregnant subjects 
(*P , 0.05). D) Serum TNF level in different trimesters of pregnancy and non pregnant subjects. TNF level was significantly higher in the 1st, 2nd and 3rd 
trimesters of pregnancy as compared non pregnant subjects (***P , 0.0001; **P , 0.01).
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Our results are in agreement with several previous 
observations that found an increase in TNF-α level in 
pregnant as compared to non pregnant subjects9,15,32 but 
in contradiction with these studies, we found a negative 
correlation between gestational age and TNF-α level. 
Explanations accounting for this finding may be related 
to lifestyle of our subjects. Clapp et al reported that 
  regular weight bearing exercise during pregnancy sup-
pressed the usual pregnancy- associated changes in the 
circulating level of TNF-α.33 In our study most of preg-
nant subjects lived in a rural area with a high level of 
  physical activity. In addition,   pregnancy is associated 
with changes of   several   hormones such as   estrogen, 
  progesterone,   cortisol and 1,25 dihydroxyvitamin D3.34–36 
Some of these hormones, for instance   cortisol and cate-
cholamines and 1,25 dihydroxy D3, are potent inhibitors 
of TNF -α production by monocyte/macrophage.37–40 
Plasma  concentration  of  cortisol  was  more  elevated 
during late pregnancy than early   pregnancy.8 Therefore, 
it is possible to increase production of these hormones 
during pregnancy to be responsible for reducing mater-
nal TNF-α production.
In conclusion, our findings suggest that TNF-α and 
IL-6 do not greatly contribute to pregnancy induced 
insulin resistance in normal pregnancy.
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